Early Education Programme in Malnourished Cancer Patients

NCT ID: NCT05495165

Last Updated: 2022-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-30

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The innovation is based on the proposal to integrate the patient, just after the announcement, before or at the beginning of the treatment (before the third session of chemotherapy or radiotherapy), in a 5-day training course in a clinical site that inspires peace of mind involving the family caregiver. The therapeutic education programme is led by a multidisciplinary team whose approach is centred on dietetics, supported by tools for encouragement via socio-aesthetics, physical activity and sophrology.

The educational objective is to promote the autonomy of the patient as well as the family caregiver, to involve them in the care pathway alongside the practitioners, with a view to contain undernutrition and reverse the spiral that increases the risks of morbi-mortality.

The aim of the study is to assess patient adherence to the device, the technical and economic feasibility, and its impact on quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nutrition Aspect of Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

60 patients entered a 5-day educational device and then followed monthly for 8 months remotely by a smart phone application and dietary consultations.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Nutritional educative programme

5 days educative programme before treatment

Group Type OTHER

Therapeutic education for patients in nutrition

Intervention Type OTHER

Stakeholders give preventive therapeutic education recommandations in their specific expertize

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Therapeutic education for patients in nutrition

Stakeholders give preventive therapeutic education recommandations in their specific expertize

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Therapeutic education for patients in sophrology Therapeutic education for patients in socio-aesthetic Therapeutic education for patients in adapted physical activity Therapeutic education for patients in psychology

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female
* From 18 to 70 years old
* Patient with an ORL, pancreatic, oesogastric, duodenal or broncho-pulmonary cancer
* Patient who have not begun their treatments or patient in the beginning of their treatments, less than or equal to two sessions of chemotherapy or radiotherapy
* patient living in a private home (personal or family)
* Prognosis greater than 12 months
* Decision taken at a multidisciplinary consultation meeting (RCP) for a curative treatment
* WHO Score Performance Status ≤2
* Patient undernourished at the advertisement codes E44.1 "Mild protein-energy malnutrition" or E44.0 "Moderate protein-energy malnutrition", according to the latest HAS recommendations
* Patient not undernourished at the time of the announcement, but going to receive a treatment or combination of treatments for curative purposes, whose therapeutic sequences are known to induce nutritional complications inducing a risk of stopping treatment
* Per os nutrition
* With internet access and reachable by phone
* Patient affiliated to the social security system
* Patient information and signature of informed consent
* Patient accompanied by a family member or not

Exclusion Criteria

* Patient with severe malnutrition corresponding to at least one of the criteria\* below:

(i) BMI \< 17 kg/m². (ii) weight loss ≥ 10% in 1 month or ≥ 15% in 6 months or ≥ 15% of the usual weight before the onset of the disease (iii) albuminemia ≤ 30 g/L. (\*) Annex 15.8: HAS 2019 source : A single criterion of severe undernutrition takes precedence over one or more criteria of moderate undernutrition.
* Treatment for curative purposes not applicable
* Comorbidities that do not allow participation in the prehabilitation course (patient presenting at least one of the criteria below):

Weight greater than 130kgs (limit of resistance of the beds in the reception centre) Sensory deficits: visual, auditory, olfactory, gustatory (not allowing to follow the educational workshops) Cognitive deficit (reading, writing, counting) Physical (ability to move around and participate in activities) Patient at risk of alcohol withdrawal

* TNM coupled with a deteriorated general condition of the patient at the time of the announcement; prediction of highly mutilating surgery involving an inability to eat through the mouth; metastatic stage.
* Patient institutionalized and/or not responsible for his or her diet
* Patient requiring parenteral or artificial enteral nutrition (feeding tube, nasogastric tube, gastrostomy or feeding jejunostomy)
* History of organ failure (cirrhosis, moderate or severe renal failure, heart failure (NYHA\>2), chronic oxygen-dependent respiratory failure)
* Anaemic patient (hemoglobin level less than 9g/dL)
* Person deprived of liberty or under guardianship
* Inability to undergo the medical monitoring of the trial for geographical, social or psychological reasons.
* Pregnant woman or Breastfeeding woman
* A delay before the first treatment does not allow inclusion in the NEHOTEL prehabilitation.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beauvais Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sif Dr Bendjaballah, Doctor

Role: PRINCIPAL_INVESTIGATOR

Beauvais Hospital

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Philippe Dr Pouillart, Doctor

Role: CONTACT

6 13 03 02 11 ext. +33

Mathilde Harleux, Engineer

Role: CONTACT

3 44 11 28 86 ext. +33

References

Explore related publications, articles, or registry entries linked to this study.

Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hutterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Muhlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017 Feb;36(1):11-48. doi: 10.1016/j.clnu.2016.07.015. Epub 2016 Aug 6.

Reference Type BACKGROUND
PMID: 27637832 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NEHOTEL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Nutrition and Chemotherapy
NCT03840213 UNKNOWN
CAncer, NUtrition and Taste 2
NCT05027490 COMPLETED NA